Toward an antifibrotic therapy for inflammatory bowel disease

14Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fibrosis in inflammatory bowel disease (IBD) is a largely unresolved clinical problem. Despite recent advances in anti-inflammatory therapies over the last few decades, the occurrence of intestinal strictures in Crohn’s disease patients has not significantly changed. No antifibrotic therapies are available. This journal supplement will address novel mechanisms of intestinal fibrosis, biomarker and imaging techniques and is intended to provide a roadmap toward antifibrotic therapies in IBD.

Cite

CITATION STYLE

APA

Rieder, F. (2016). Toward an antifibrotic therapy for inflammatory bowel disease. United European Gastroenterology Journal, 4(4), 493–495. https://doi.org/10.1177/2050640616660000

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free